National Institute of Health and Care Excellence (NICE)
80 episodes
6 days ago
We're joined by representatives from the MHRA to discuss how NHS patients will be able to access medicines up to 6 months faster through an aligned MHRA and NICE pathway.
Watch the webinar here: https://www.youtube.com/watch?v=FVBVYTUc2Q4
All content for NICE Talks is the property of National Institute of Health and Care Excellence (NICE) and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
We're joined by representatives from the MHRA to discuss how NHS patients will be able to access medicines up to 6 months faster through an aligned MHRA and NICE pathway.
Watch the webinar here: https://www.youtube.com/watch?v=FVBVYTUc2Q4
In this episode, we discuss recent analysis showing significant disparities in SGLT-2 inhibitor prescriptions for people with type 2 diabetes in England.
We also explore how our new draft recommendations for these medications could increase uptake with our three guests.
They are: Dr Waqaar Shah, chair of the type 2 diabetes guideline committee; Dr Soon Song, consultant physician and diabetologist at Sheffield Teaching Hospitals NHS Foundation Trust; Dr Rahul Mohan, a GP and secretary of the Primary Care Diabetes Society.
Learn more about: www.nice.org.uk/news/articles/wom…r-type-2-diabetes
Read our draft guideline for type 2 diabetes medicines management: www.nice.org.uk/guidance/gid-ng10336/documents/450
NICE Talks
We're joined by representatives from the MHRA to discuss how NHS patients will be able to access medicines up to 6 months faster through an aligned MHRA and NICE pathway.
Watch the webinar here: https://www.youtube.com/watch?v=FVBVYTUc2Q4
